| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 8 |
| 1 | APIXABAN | 7 |
| 2 | DAPAGLIFLOZIN | 7 |
| 3 | ONDANSETRON | 7 |
| 4 | ONDANSETRON HYDROCHLORIDE | 7 |
| 5 | POTASSIUM CHLORIDE | 7 |
| 6 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 7 |
| 7 | POTASSIUM CHLORIDE ORAL | 7 |
| 8 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 7 |
| 9 | BORTEZOMIB | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIDODRINE HYDROCHLORIDE | 6 | 0.0013 |
| 1 | BRENSOCATIB | 1 | 0.0004 |
| 2 | VUTRISIRAN | 1 | 0.0003 |
| 3 | LEUCOVORIN CALCIUM | 6 | 0.0003 |
| 4 | DROXIDOPA | 6 | 0.0003 |
| 5 | OXAZEPAM | 6 | 0.0003 |
| 6 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 4 | 0.0003 |
| 7 | SODIUM BICARBONATE INJECTION, | 6 | 0.0003 |
| 8 | RIPRETINIB | 1 | 0.0002 |
| 9 | MAVACAMTEN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Cardiac Glycoside [EPC] | 4 | 0.0001 |
| 5 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 6 | Proteasome Inhibitor [EPC] | 6 | 0.0001 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 7 | 0.0000 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |